Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Breast-conserving therapy in women with BRCA1/2-linked disease has pros, cons
December 16th, 2004
Women with hereditary breast cancer treated with breast-conserving therapy appear to have no increased risk for recurrence in the treated breast, according to results from a prospective study. But the study also shows the risk of breast cancer in the opposite breast is significantly increased in such women. The findings, published online November 22, 2004, will be published in the January 1, 2005, issue of Cancer. Breast-conserving therapy (BCT), consisting of lumpectomy and radiation, has been demonstrated to be a safe, effective treatment for non-hereditary or sporadic forms of early breast cancer. However, for hereditary...
Source: Women's Health Weekly (2004-12-16)
|
